BOME Therapeutics
PrivateCompany Overview
BOME Therapeutics is a biotechnology company developing allergen immunotherapy vaccines based on its proprietary Antigen Delivery by Precipitation (ADBP) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BOME Therapeutics Comparables
Compare BOME Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hapten Sciences, Inc. | 90% | |
| Angany | 76% | |
| Desentum Oy | 72% |
BOME Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 55% MoM.
BOME Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BOME Therapeutics's valuation, stock price, and market status.
Is BOME Therapeutics a public or private company?
BOME Therapeutics is a private company.
What is the current stock price of BOME Therapeutics?
BOME Therapeutics is a private company with no public stock price. Caplight tracks BOME Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is BOME Therapeutics worth (valuation)?
Valuation information for BOME Therapeutics is not publicly available.
Can I buy BOME Therapeutics stock?
BOME Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BOME Therapeutics's last funding round?
Funding round information for BOME Therapeutics is not publicly available.
Who are the main investors in BOME Therapeutics?
Investor information for BOME Therapeutics is not publicly disclosed.
Will BOME Therapeutics IPO soon?
No public IPO plans have been announced for BOME Therapeutics.
How can I track BOME Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BOME Therapeutics's secondary market activity and sign up for updates.